Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chevillard C., Duchene N., Alexander J. M. Selective release of newly synthesized cardiac norepinephrine induced by angiotensin II. Eur J Pharmacol. 1971 Jun;15(1):8–14. doi: 10.1016/0014-2999(71)90071-9. [DOI] [PubMed] [Google Scholar]
- Ferrone R. A., Antonaccio M. J. Prevention of the development of spontaneous hypertension in rats by captopril (SQ 14,225). Eur J Pharmacol. 1979 Dec 7;60(2-3):131–137. doi: 10.1016/0014-2999(79)90211-5. [DOI] [PubMed] [Google Scholar]
- Judy W. V., Watanabe A. M., Henry D. P., Besch H. R., Jr, Murphy W. R., Hockel G. M. Sympathetic nerve activity: role in regulation of blood pressure in the spontaenously hypertensive rat. Circ Res. 1976 Jun;38(6 Suppl 2):21–29. doi: 10.1161/01.res.38.6.21. [DOI] [PubMed] [Google Scholar]
- Man in 't Veld A. J., Schicht I. M., Derkx F. H., de Bruyn J. H., Schalekamp M. A. Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects. Br Med J. 1980 Feb 2;280(6210):288–290. doi: 10.1136/bmj.280.6210.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Okuno T., Kondo K., Konishi K., Saruta T., Kato E. SQ 14,225 attenuates the vascular response to norepinephrine in the rat mesenteric arteries. Life Sci. 1979 Oct 8;25(15):1343–1349. doi: 10.1016/0024-3205(79)90401-6. [DOI] [PubMed] [Google Scholar]
- Rubin B., Laffan R. J., Kotler D. G., O'Keefe E. H., Demaio D. A., Goldberg M. E. SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme. J Pharmacol Exp Ther. 1978 Feb;204(2):271–280. [PubMed] [Google Scholar]
- Vandongen R., Peart W. S., Boyd G. W. Andrenergic stimulation of renin secretion in the isolated perfused rat kidney. Circ Res. 1973 Feb;32(2):290–296. doi: 10.1161/01.res.32.2.290. [DOI] [PubMed] [Google Scholar]